Not finding it? Sign in to also search OpenAlex live.
-
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT
Meral Beksaç, Dirk‐Jan Eikema, Linda Köster, Cyrille Hulin, Xavier Poiré, Rose‐Marie Hamladji, +19 more
0citations -
Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge
Mark Schuiveling, Hong Liu, Daniel Eek, Martina Hanusová, Isabella A.J. van Duin, Laurens S. ter Maat, +30 more
0citations -
In-Hospital and 6-Month Outcomes of COVID-19 Patients Supported with Extracorporeal Membrane Oxygenation: The EuroECMO-COVID Multicenter Prospective Observational Study2022 SSRN Electronic Journal preprint Engineering Mechanical Circulatory Support Devices Open access
Roberto Lorusso, Maria Elena De Piero, Silvia Mariani, Michele Di Mauro, Valeria Lo Coco, Thierry A Folliguet, +43 more
2citations -
Oncological Outcomes after a Pathological Complete Response Following Total Neoadjuvant Therapy or Chemoradiotherapy for High-Risk Locally Advanced Rectal Cancer in the RAPIDO Trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, H. Putter, Irıs D. Nagtegaal, +9 more
2citations -
A new inverse probability of selection weighted Cox model to deal with outcome-dependent sampling in survival analysis2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Mathematics Statistical Methods in Epidemiology Open access
Vera H. Arntzen, Marta F. Fiocco, Inge M. M. Lakeman, Maartje Nielsen, Mar Rodríguez‐Girondo
1citations